Company profile: Micro Interventional Devices
1.1 - Company Overview
Company description
- Provider of percutaneous and minimally invasive structural heart repair technologies, including PolyCor polymeric anchors for soft-tissue cardiac applications; the MIA-T and MIA-M percutaneous annuloplasty systems for tricuspid and mitral valve regurgitation; and the Transcatheter Cardiac Repair platform enabling catheter-based treatment of structural heart disease without cardiopulmonary bypass.
Products and services
- Transcatheter Cardiac Repair (TCR) Platform: Catheter-based platform that treats structural heart disease without cardiopulmonary bypass, enabling percutaneous, minimally invasive repair via transcatheter procedures for structural cardiac interventions
- MIA-T Percutaneous Annuloplasty System for Tricuspid Valve Repair: Polymeric-anchor–assisted percutaneous system that addresses tricuspid valve regurgitation, utilizing proprietary PolyCor anchors for soft-tissue implantation in cardiac procedures
- MIA-M Percutaneous Annuloplasty System for Mitral Valve Repair: Percutaneous system mitigating mitral valve regurgitation, leveraging technology and application similar to MIA-T for annuloplasty in structural heart repair
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Micro Interventional Devices
Saranas
HQ: United States
Website
- Description: Provider of a medical device that detects internal bleeding during catheterization procedures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Saranas company profile →
InaVein
HQ: United States
Website
- Description: Provider of innovative products to treat the full spectrum of vein disorders. Founded in 2007, InaVein develops and commercializes technologies including the TRIVEX System, which uses direct visualization to completely remove varicose veins in a shorter period of time compared to conventional phlebectomy procedures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InaVein company profile →
XO1
HQ: United Kingdom
Website
- Description: Provider of virtual biotechnology development focused on ichorcumab, operating without offices or laboratories by engaging high-quality contract research and development specialists in Europe and the US, managed by a small team of experienced drug developers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full XO1 company profile →
Boston Heart Diagnostics
HQ: United States
Website
- Description: Provider of cardiovascular disease management solutions, combining proprietary lipid testing, advanced diagnostics, therapy guidelines, and patient support. Offerings include CVMap, Polygenic Risk Map, LipoMap NMR lipid panel, dried blood spot testing with 40+ assays, advanced lipid tests for risk stratification and chronic care, and a tailored lifestyle program for long-term health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Boston Heart Diagnostics company profile →
Cardiovascular Systems
HQ: United States
Website
- Description: Provider of medical devices for treating peripheral and coronary vascular disease, focusing on plaque removal via orbital atherectomy systems (Diamondback 360 Peripheral and Coronary OAS, Stealth 360), as well as guide wires (ViperWire Advance, Shepherd) and support catheters (ViperCross), helping physicians address difficult disease states, including calcium.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardiovascular Systems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Micro Interventional Devices
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Micro Interventional Devices
2.2 - Growth funds investing in similar companies to Micro Interventional Devices
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Micro Interventional Devices
4.2 - Public trading comparable groups for Micro Interventional Devices
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →